Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease
Public ClinicalTrials.gov record NCT00058838. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Double-Blind, Placebo-Controlled, Fixed-Dose Response Study Comparing the Efficacy and Safety of Sumanirole Versus Placebo in Patients With Early Parkinson's Disease.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to determine whether sumanirole, at three different dose levels, is effective and safe in the treatment of the signs and symptoms of early Parkinson's disease
Study identification
- NCT ID
- NCT00058838
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 854 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2003 (Type not available)
- Primary completion
- Not listed
- Completion
- Sep 2004 (Type not available)
- Last update posted
- Jun 7, 2006
2003 – 2004
United States locations
- U.S. sites
- 69
- U.S. states
- 26
- U.S. cities
- 63
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | 35249-7340 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 35294 | — |
| Pfizer Investigational Site | Huntsville | Alabama | 35801 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72205 | — |
| Pfizer Investigational Site | Concord | California | 94520 | — |
| Pfizer Investigational Site | Irvine | California | 92618 | — |
| Pfizer Investigational Site | La Jolla | California | 92037 | — |
| Pfizer Investigational Site | Loma Linda | California | 92354 | — |
| Pfizer Investigational Site | Oceanside | California | 92056 | — |
| Pfizer Investigational Site | Oxnard | California | 93030 | — |
| Pfizer Investigational Site | San Francisco | California | 94109 | — |
| Pfizer Investigational Site | San Francisco | California | 94115 | — |
| Pfizer Investigational Site | Sunnyvale | California | 94089 | — |
| Pfizer Investigational Site | Walnut Creek | California | 94598 | — |
| Pfizer Investigational Site | Englewood | Colorado | 80113 | — |
| Pfizer Investigational Site | Fort Collins | Colorado | 85624 | — |
| Pfizer Investigational Site | Fairfield | Connecticut | 06430 | — |
| Pfizer Investigational Site | Hartford | Connecticut | 06106 | — |
| Pfizer Investigational Site | Fort Lauderdale | Florida | 33308 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32216 | — |
| Pfizer Investigational Site | Maitland | Florida | 32751 | — |
| Pfizer Investigational Site | Miami | Florida | 33136 | — |
| Pfizer Investigational Site | Palm Beach Gardens | Florida | 33410 | — |
| Pfizer Investigational Site | Sarasota | Florida | 34243 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33701 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33703-2612 | — |
| Pfizer Investigational Site | Tallahasse | Florida | 32308 | — |
| Pfizer Investigational Site | Tampa | Florida | 33609-4052 | — |
| Pfizer Investigational Site | Tampa | Florida | 33614 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30338 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30033 | — |
| Pfizer Investigational Site | Marietta | Georgia | 30060 | — |
| Pfizer Investigational Site | Savannah | Georgia | 31405 | — |
| Pfizer Investigational Site | Elkhart | Indiana | 46514 | — |
| Pfizer Investigational Site | Des Moines | Iowa | 50309 | — |
| Pfizer Investigational Site | Dubuque | Iowa | 52001 | — |
| Pfizer Investigational Site | Kansas City | Kansas | 66160 | — |
| Pfizer Investigational Site | Crestview Hills | Kentucky | 41017 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40503 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40202 | — |
| Pfizer Investigational Site | Scarborough | Maine | 04074 | — |
| Pfizer Investigational Site | Baltimore | Maryland | — | — |
| Pfizer Investigational Site | Frederick | Maryland | 21702 | — |
| Pfizer Investigational Site | Southfield | Michigan | 48034 | — |
| Pfizer Investigational Site | Springfield | Missouri | 65804 | — |
| Pfizer Investigational Site | Springfield | Missouri | 65807 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89052 | — |
| Pfizer Investigational Site | Lebanon | New Hampshire | 03766 | — |
| Pfizer Investigational Site | Albany | New York | 12208 | — |
| Pfizer Investigational Site | The Bronx | New York | 10461 | — |
| Pfizer Investigational Site | Asheville | North Carolina | 28801 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28209 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Canfield | Ohio | 44406 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44195 | — |
| Pfizer Investigational Site | Dayton | Ohio | 45408 | — |
| Pfizer Investigational Site | Dayton | Ohio | 45415 | — |
| Pfizer Investigational Site | Bend | Oregon | 97701 | — |
| Pfizer Investigational Site | Eugene | Oregon | 97401 | — |
| Pfizer Investigational Site | Portland | Oregon | 97209 | — |
| Pfizer Investigational Site | Sellersville | Pennsylvania | 18960 | — |
| Pfizer Investigational Site | Upland | Pennsylvania | 19013-3995 | — |
| Pfizer Investigational Site | Houston | Texas | 77030 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23294 | — |
| Pfizer Investigational Site | Spokane | Washington | 99204 | — |
| Pfizer Investigational Site | Tacoma | Washington | 98405 | — |
| Pfizer Investigational Site | Wenatchee | Washington | 98801 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00058838, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2006 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00058838 live on ClinicalTrials.gov.